Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure

British Journal of Clinical Pharmacology

Volumn 64, Issue 6, 2007, Pages 738-744

  Asari, Ashwin ^a   Iles Smith, Heather ^a   Chen, Ya Chi ^b   Naderer, Odin J ^b   Johnson, Mark A ^b   Yuen, Geoffrey J ^b   Otto, Vicky ^b   Dunn, John A ^b   Gokal, Ram ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

3TC; ESRD; Lamivudine; Peritoneal dialysis; Pharmacokinetics; Zeffix

Indexed keywords

LAMIVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; DIARRHEA; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SAFETY; EYE DISEASE; EYE REDNESS; FEMALE; GASTRITIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LAMIVUDINE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 36849086972     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02963.x     Document Type: Article

References (15)

1. GlaxoSmithKline Clinical Trial Registry. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom (updated July 4th, 2005). Available from: http://ctr.gsk.co.uk/Summarylamivudine/II_NUCB2002.pdf
2. Lessells R, Leen C. Management of hepatitis B in patients co-infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 2004 23 : 366 74.
3. Clercq ED. Antiviral drugs in current clinical use. J Clin Virol 2004 30 : 115 33.
4. Doong S-L, Tsai C-H, Shinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′3′-dideoxy- 3′thiacytidine and related analogues. Proc Nat Acad Sci 1991 88 : 8495 9.
5. Pluda JM, Cooley TP, Montaner JS, Shay LE, Reinhalter NE, Warthan SN, Ruedy J, Hirst HM, Vicary CA, Quinn JB, Yuen GJ, Wainberg MA, Rubin M, Yarchoan R. A phase I/II study of 2′-deoxy-3′-thiacytidine (lamivudine) in subjects with advanced human immunodeficiency virus infection. J Infect Dis 1995 171 : 1438 47.
6. Van Leeuwen R, Lange JMA, Hussey EK, Donn KH, Hall ST, Harker AJ, Jonker P, Danner SA. The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3-TC, in subjects with HIV infection: a phase I study. AIDS 1992 6 : 1415 7.
7. Heald AE, Hsyu PH, Yuen GJ, Robinson P, Mydlow P, Bartlett JA. Pharmacokinetics of lamivudine in human immunodeficiency virus-infected subjects with renal dysfunction. Antimicrob Agents Chemother 1996 40 : 31 41.
8. Yuen GJ, Morris DM, Mydlow PK, Haidar S, Hall ST, Hussey EK. Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine. J Clin Pharmacol 1995 35 : 1174 80.
9. Johnson MA, Verpooten GA, Daniel MJ, Plumb R, Moss J, Van Caesbroeck D, De Broe ME. Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysis. Br J Clin Pharmacol 1998 46 : 21 7.
10. Perry CM, Faulds D. Lamivudine, a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs 1997 53 : 657 80.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
12. Harker AJ, Evans GL, Hawley AE, Morris DM. High-performance liquid chromatographic assay for 2′-deoxy-3′-thiacytidine in human serum. J Chromatogr B Biomed Appl 1994 657 : 227 32.
13. Plumb RS, Gray RD, Harker AJ, Taylor S. High-performance chromatographic assay for the sulphoxide metabolite of 2′-deoxy-3′-thiacytidine in human urine. Chromatogr B Biomed Appl 1996 687 : 457 61.
14. Hsyu PH, Lloyd TL. Automated high-performance chromatographic analysis of (-) -2′-deoxy-3′-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems. Chromatogr B Biomed Appl 1994 655 : 253 9.
15. Johnson MA, Moore KHP, Yuen GJ, Bye A, Pakes GE. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 1999 36 : 41 66.